Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Proteinuria Determined by Automated Analyzer

By LabMedica International staff writers
Posted on 03 Jul 2012
Print article
A rapid, accurate, and cost-effective method for their detection of protein in urine has been developed for the autoanalyzer.

The method is a two-reagent system consists of a buffer solution and surfactants, and a second one consists of a dye solution of Erythrosin B being added to a urine sample, and the dye bound protein is measured by a spectrophotometer.

At the Juntendo University (Tokyo, Japan) nephrologists enrolled 70 outpatients who were screened for proteinuria by the dipstick test. Spot urine samples from the patients and 79 healthy volunteers were examined. Urine samples were stored at -80 °C. A solution containing a buffer agent with a pH 2.3 and surfactants and a solution of Erythrosin B are added to each urine sample. After letting the mixture stand for five minutes at 37 °C, the dye-bound protein is measured by a spectrophotometer at 546 nm using an automated analyzer.

The calibration curve was linear with human serum albumin concentration in the range of 2.4-200 mg/L. The detection limit, 2.4 mg/L was superior to conventional dye-binding methods by one order of magnitude and comparable to the turbidimetric immunoassay (TIA), which is quite expensive. There was an excellent correlation between the results given by the Erythrosin B (Wako Pure Chemical Industries Ltd., Tokyo, Japan) method and those by the TIA.

The authors concluded that the method is equal to the dipstick test in terms of time and cost savings. The reaction was completed within 5 minutes at 37 °C after mixing the test solution, and could be coupled with the 7170S automated analyzer (Hitachi, Tokyo, Japan) for rapid detection. The method was capable of determining actual samples without being influenced by foreign substances in urine such as urea, creatinine, and glucose. This method is sufficiently sensitive for the detection of trace proteinuria in early-stage of chronic kidney disease, and is directly applicable to actual samples. The study was published in the July 2012 issue of the journal Clinica Chimica Acta.

Related Links:

Juntendo University
Wako Pure Chemical Industries Ltd.
Hitachi



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
HIV Test
Anti-HIV (1/2) Rapid Test Kit

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.